Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Tatva Chintan Pharma IPO is a book built issue of Rs 500.00 crores. The issue is a combination of fresh issue of Rs 225.00 crores and offer for sale of Rs 275.00 crores.
Tatva Chintan Pharma IPO bidding started from July 16, 2021 and ended on July 20, 2021. The allotment for Tatva Chintan Pharma IPO was finalized on Monday, July 26, 2021. The shares got listed on BSE, NSE on July 29, 2021.
Tatva Chintan Pharma IPO price band is set at ₹1073 to ₹1083 per share. The minimum lot size for an application is 13 Shares. The minimum amount of investment required by retail investors is ₹14,079.
ICICI Securities Limited and Jm Financial Limited are the book running lead managers of the Tatva Chintan Pharma IPO, while Link Intime India Private Ltd is the registrar for the issue.
Refer to Tatva Chintan Pharma IPO RHP for detailed information.
| IPO Date | July 16, 2021 to July 20, 2021 |
| Listing Date | July 29, 2021 |
| Face Value | ₹10 per share |
| Price Band | ₹1073 to ₹1083 per share |
| Lot Size | 13 Shares |
| Total Issue Size | [.] shares (aggregating up to ₹500.00 Cr) |
| Fresh Issue | [.] shares (aggregating up to ₹225.00 Cr) |
| Offer for Sale | [.] shares of ₹10 (aggregating up to ₹275.00 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 20,087,500 |
| Share holding post issue | 22,165,062 |
Tatva Chintan Pharma IPO offers 3,261,882 shares. 931,966 (28.57%) to QIB, 698,975 (21.43%) to NII, 1,630,941 (50.00%) to RII. 125,457 RIIs will receive minimum 13 shares and (sNII) and (bNII) will receive minimum 195 shares. (in case of oversubscription)
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | - | NA |
| QIB Shares Offered | 931,966 (28.57%) | NA |
| NII (HNI) Shares Offered | 698,975 (21.43%) | |
| Retail Shares Offered | 1,630,941 (50.00%) | 125,457 |
| Total Shares Offered | 3,261,882 (100%) |
Tatva Chintan Pharma IPO opens on July 16, 2021, and closes on July 20, 2021.
| IPO Open Date | Friday, July 16, 2021 |
| IPO Close Date | Tuesday, July 20, 2021 |
| Basis of Allotment | Monday, July 26, 2021 |
| Initiation of Refunds | Tuesday, July 27, 2021 |
| Credit of Shares to Demat | Wednesday, July 28, 2021 |
| Listing Date | Thursday, July 29, 2021 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 20, 2021 |
Investors can bid for a minimum of 13 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 13 | ₹14,079 |
| Retail (Max) | 14 | 182 | ₹197,106 |
| Lot Size Calculator | |||
Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.
| Share Holding Pre Issue | 100% |
| Share Holding Post Issue | 79.17% |
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
Competitive strengths
| Particulars | For the year/period ended (₹ in million) | ||||
|---|---|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |||
| Total Assets | 3,148.03 | 2,489.38 | 1,875.08 | ||
| Total Revenue | 3,062.92 | 2,646.22 | 2,068.01 | ||
| Profit After Tax | 522.62 | 377.89 | 205.43 | ||
[Dilip Davda] The company is in a fast forward mode and the issue is reasonably priced. The green chemical industry is fancied by investors across the board. Investment may be considered for short to long term rewards. Read detail review...
The Tatva Chintan Pharma IPO is subscribed 180.36 times on July 20, 2021 5:01:00 PM. The public issue subscribed 35.35 times in the retail category, 185.23 times in the QIB category, and 512.22 times in the NII category. Check Day by Day Subscription Details (Live Status)
Application Wise IPO Subscription (Retail): 26.1 times
| Category | Subscription (times) |
|---|---|
| QIB | 185.23 |
| NII | 512.22 |
| Retail | 35.35 |
| Total | 180.36 |
| Listing Date | July 29, 2021 |
| BSE Script Code | 543321 |
| NSE Symbol | TATVA |
| ISIN | INE0GK401011 |
| Final Issue Price | ₹1083 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE |
|---|
| ₹1,083.00 |
| ₹2,111.80 |
| ₹2,111.80 |
| ₹2,486.30 |
| ₹2,310.25 |
| NSE |
|---|
| ₹1,083.00 |
| ₹2,111.85 |
| ₹2,111.85 |
| ₹2,534.20 |
| ₹2,312.20 |
Tatva Chintan Pharma Chem Ltd
Plot No. 502 / 17, GIDC Estate, Ankleshwar,
Bharuch, Gujarat - 393002, India
Phone: +91 75730 46951
Email: cs@tatvachintan.com
Website: http://www.tatvachintan.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: tatva.ipo@linkintime.co.in
Website: https://linkintime.co.in/initial_offer/public-issues.html
Tatva Chintan Pharma IPO is a main-board IPO of [.] equity shares of the face value of ₹10 aggregating up to ₹500.00 Crores. The issue is priced at ₹1073 to ₹1083 per share. The minimum order quantity is 13 Shares.
The IPO opens on July 16, 2021, and closes on July 20, 2021.
Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Tatva Chintan Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Tatva Chintan Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Tatva Chintan Pharma IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Tatva Chintan Pharma IPO opens on July 16, 2021 and closes on July 20, 2021.
Tatva Chintan Pharma IPO lot size is 13 Shares, and the minimum amount required is ₹14,079.
You can apply in Tatva Chintan Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Tatva Chintan Pharma IPO will be done on Monday, July 26, 2021, and the allotted shares will be credited to your demat account by Wednesday, July 28, 2021. Check the Tatva Chintan Pharma IPO allotment status.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
IPO Guru (2000+ Posts, 1700+ Likes)
Top Contributor (300+ Posts, 100+ Likes)
IPO Mentor (700+ Posts, 700+ Likes)
rohan sharma| Link | Bookmark |August 17, 2021 12:13:03 PM